Product Information

RIVAROXABAN 2.5 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.6265 per EA under NDC 59651084918. Its NADAC has been published 77 times since May 28, 2025.

FDA first approved this application on Apr 10, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RIVAROXABAN 2.5 MG TABLET

Rivaroxaban
$0.6265per EA

Strength

2.5 mg/1

NDC

59651084918

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

RIVAROXABAN

Approval Type

Generic (ANDA)

FDA Application

ANDA208544

FDA Approved

4/10/2025

TE Code

AB

On Market Since

4/10/2025

Pharmacological Classes

Factor Xa Inhibitor
Factor Xa Inhibitors

Price Statistics

The NADAC for RIVAROXABAN 2.5 MG TABLET has been published 77 times since May 28, 2025, and over the history we have for it it has declined 85.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6265 per EA
All-time high$4.6446 (Aug 13, 2025)
All-time low$0.6265 (Oct 21, 2026)
52-week high$1.6224
52-week low$0.6265
Median price$1.0757
Average price$1.9239
Largest weekly change-32.4% (Nov 19, 2025)
Weeks tracked77
Tracking sinceMay 28, 2025

Price History

1W

0.0%

1M

-3.6%

3M

-9.4%

6M

-28.2%

1Y

-73.9%

3Y

N/A

5Y

N/A

All

-85.6%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of RIVAROXABAN 2.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for RIVAROXABAN 2.5 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.6265 per EA (NDC 59651084918), effective Nov 11, 2026.

How has the price of RIVAROXABAN 2.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for RIVAROXABAN 2.5 MG TABLET has declined 85.6%. It has been tracked across 77 weekly CMS publications since May 28, 2025.

What are the highest and lowest recorded NADAC prices for RIVAROXABAN 2.5 MG TABLET?

Since May 28, 2025, the NADAC for RIVAROXABAN 2.5 MG TABLET has ranged from a low of $0.6265 (Oct 21, 2026) to a high of $4.6446 (Aug 13, 2025), with a median of $1.0757 per EA.

Are there cheaper alternatives to RIVAROXABAN 2.5 MG TABLET?

7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RIVAROXABAN 2.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures RIVAROXABAN 2.5 MG TABLET?

RIVAROXABAN 2.5 MG TABLET (NDC 59651084918) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.